Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PW Medtech Group's Enterprise Value is HK$-106.5 Mil.
PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil. Therefore, PW Medtech Group's EV-to-EBIT ratio for today is -0.42.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, PW Medtech Group's Enterprise Value is HK$-106.5 Mil.
PW Medtech Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil. Therefore, PW Medtech Group's EV-to-EBITDA ratio for today is -0.42.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, PW Medtech Group's Enterprise Value is HK$-106.5 Mil.
PW Medtech Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$738.4 Mil. Therefore, PW Medtech Group's EV-to-Revenue ratio for today is -0.14.
PW Medtech Group Enterprise Value Historical Data
The historical data trend for PW Medtech Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PW Medtech Group's Enterprise Value
For the Medical Instruments & Supplies subindustry, PW Medtech Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's Enterprise Value falls into.
PW Medtech Group Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
PW Medtech Group's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (HKSE:01358) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
PW Medtech Group's current Enterprise Value is HK$-106.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
PW Medtech Group's current Enterprise Value is HK$-106.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil.
PW Medtech Group's current Enterprise Value is HK$-106.5 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$738.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group Enterprise Value Related Terms
Thank you for viewing the detailed overview of PW Medtech Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
PW Medtech Group (HKSE:01358) Business Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01358 has been successfully added to your 